1 |
Vaughan S, Coward JI, Bast RC, et al (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer, 11, 719-25.
DOI
ScienceOn
|
2 |
Wang B1, Liu SZ, Zheng RS, et al (2014). Time trends of ovarian cancer incidence in China. Asian Pac J Cancer Prev, 15, 191-3.
과학기술학회마을
DOI
ScienceOn
|
3 |
Wells G, Shea B, O'connell D, et al (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. URL: http://www. ohri. ca/programs/clinical_epidemiology/oxford. asp
|
4 |
Westerlind KC (2003). Physical activity and cancer prevention-mechanisms. Med Sci Sports Exerc, 35, 1834-40.
DOI
ScienceOn
|
5 |
Wu SPL, Cao HX, Liu YT, et al (2009). Body size, physical activity and risk of breast cancer.a case control study in Jangsu Province of China. Asian Pac J Cancer Prev, 10, 877-81.
|
6 |
Zhang M, Lee AH, Binns CW (2003). Physical activity and epithelial ovarian cancer risk: a case-control study in China. Int J Cancer, 105, 838-43.
DOI
ScienceOn
|
7 |
Zhao SH, Wang Y, Wen L, et al (2013). Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer. J Transl Med, 11, 92.
DOI
|
8 |
Rossing MA, Cushing-Haugen KL, Wicklund KG, et al (2010). Recreational physical activity and risk of epithelial ovarian cancer. Cancer Causes Control, 21, 485-91.
DOI
|
9 |
Patel AV, Rodriguez C, Pavluck AL, et al (2006). Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. Am J Epidemiol, 163, 709-16.
DOI
ScienceOn
|
10 |
Riman T, Nilsson S, Persson IR (2004). Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand, 83, 783-95.
DOI
|
11 |
Risch HA (1998). Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst, 90, 1774-86.
DOI
ScienceOn
|
12 |
Salehi F, Dunfield L, Phillips KP, et al (2008). Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev, 11, 301-21.
DOI
ScienceOn
|
13 |
Tavani A, Gallus S, La Vecchia C, et al (2001). Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer, 91, 407-11.
DOI
|
14 |
Samuels Y, Waldman T (2011). Oncogenic mutations of PIK3CA in human cancers. Phosphoinositide 3-kinase in Health and Disease. Springer.
|
15 |
Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011. CA Cancer J Clin, 61, 212-36.
DOI
|
16 |
Society AC (2005). Cancer facts & figures, Atlanta, GA: American Cancer Society.
|
17 |
Thune I (2000). Assessments of physical activity and cancer risk. Eur J Cancer Prev, 9, 387-93.
DOI
|
18 |
Vainio H, Bianchini F (2002). Weight control and physical activity. IARC Handbooks of Cancer Prevention. IARC Press Lyon.
|
19 |
Lahmann PH, Friedenreich C, Schulz M, et al (2009). Physical activity and ovarian cancer risk: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev, 18, 351-4.
DOI
ScienceOn
|
20 |
Kruk J (2007). Physical activity in the prevention of the most frequent chronic diseases: an analysis of the recent evidence. Asian Pac J Cancer Prev, 8, 325.
|
21 |
Kruk J, Aboul-Enein HY (2006). Physical activity in the prevention of cancer. Asian Pac J Cancer Prev, 7, 11.
|
22 |
Lee JE , Loh SY (2013). Physical activity and quality of life of cancer survivors: a lack of focus for lifestyle redesign. Asian Pac J Cancer Prev, 14, 2551-5.
과학기술학회마을
DOI
ScienceOn
|
23 |
Pan SY, Johnson KC, Ugnat A-M, et al (2004). Association of obesity and cancer risk in Canada. Am J Epidemiol, 159, 259-68.
DOI
ScienceOn
|
24 |
Lin J, Spidel JL, Maddage CJ, et al (2013). The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity. Cancer Biol Ther, 14, 1032-8.
DOI
|
25 |
Munksgaard PS, Blaakaer J (2012). The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol, 124, 164-9.
DOI
ScienceOn
|
26 |
Ness RB, Cottreau C (1999). Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst, 91, 1459-67.
DOI
|
27 |
Cramer DW , Welch WR (1983). Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst, 71, 717-21.
|
28 |
Burger RA, Brady MF, Bookman MA, et al (2011). Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med, 365, 2473-83.
DOI
ScienceOn
|
29 |
Campbell KL , McTiernan A (2007). Exercise and biomarkers for cancer prevention studies. J Nutr, 137, 161-9.
DOI
|
30 |
Cauley JA, Gutai JP, Kuller LH, et al (1989). The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol, 129, 1120-31.
DOI
|
31 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
ScienceOn
|
32 |
Duval S, Tweedie R (2000). Trim and fill: a simple funnel-plot.based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455-63.
DOI
ScienceOn
|
33 |
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. Br Med J, 327, 557.
DOI
ScienceOn
|
34 |
Egger M, Smith GD, Schneider M , Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. Br Med J, 315, 629-34.
DOI
ScienceOn
|
35 |
Friedenreich CM (2001). Physical activity and cancer: lessons learned from nutritional epidemiology. Nutr Rev, 59, 349-57.
|
36 |
Hannan LM, Leitzmann MF, Lacey JV, et al (2004). Physical activity and risk of ovarian cancer: a prospective cohort study in the United States. Cancer Epidemiol Biomarkers Prev, 13, 765-70.
|
37 |
Ainsworth BE, Haskell WL, Whitt MC, et al (2000). Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc, 32, 498-504.
DOI
|
38 |
Aktas G, Ogce F (2005). Dance as a therapy for cancer prevention. Asian Pac J Cancer Prev, 6, 408.
|
39 |
Anderson JP, Ross JA , Folsom AR (2004). Anthropometric variables, physical activity, and incidence of ovarian cancer. Cancer, 100, 1515-21.
DOI
ScienceOn
|
40 |
Antoniou AC, Rookus M, Andrieu N, et al (2009). Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev, 18, 601-10.
DOI
ScienceOn
|
41 |
Begg CB , Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
ScienceOn
|
42 |
Pan SY, Ugnat AM , Mao Y (2005). Physical activity and the risk of ovarian cancer: a case-control study in Canada. Int J Cancer, 117, 300-7.
DOI
ScienceOn
|
43 |
Bertone ER, Newcomb PA, Willett WC, et al (2002). Recreational physical activity and ovarian cancer in a population-based case-control study. Int J Cancer, 99, 431-6.
DOI
ScienceOn
|
44 |
Kim JH, Jeong SJ, Kim B, et al (2012). Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. J Pineal Res, 52, 244-52.
DOI
ScienceOn
|
45 |
Bertone ER, Willett WC, Rosner BA, et al (2001). Prospective study of recreational physical activity and ovarian cancer. J Natl Cancer Inst, 93, 942-8.
DOI
ScienceOn
|
46 |
Kramer MM, Wells CL (1996). Does physical activity reduce risk of estrogen-dependent cancer in women? Med Sci Sports Exerc, 28, 322-34.
|